Toggle navigation
Home
Search
Services
Blog
Contact
About
Biologically Relevant Alpha Helix Stabilization
Erlanson, Daniel A.
Sunesis Pharmaceuticals, Inc., South San Francisco, CA, United States
Search 5 grants from Daniel Erlanson
Search grants from Sunesis Pharmaceuticals, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Response of aging intrinsic laryngeal muscles to chronic electrical stimulation
Genome-wide profiling of human vascular response to oxidized lipoprotreins
Differential Gene Expression Induced by Antioxidants
Minority High School Student Research Apprentice Program
SBIR Phase I: Vibrational CD Microscopy for Characterizing Supramolecular Bio-Chirality
Recently added grants:
Defining the mechanism and functions of RIPK1-induced cell death in anti-bacterial immune defense
Role of the ADAR1-mediated RNA editing ? RNA sensing axis in sterile inflammation
A novel multifunctional role of diverse substrate binding and import by the Haemophilus Sap transporter
Discovery of Gram-negative permeable chemical probes for tRNA methylation
Gut Microbiota and Effect on Immune Suppressants in Transplantation
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
7F32GM019454-02
Application #
2906476
Study Section
Physical Biochemistry Study Section (PB)
Program Officer
Lohrey, Nancy
Project Start
1998-12-21
Project End
Budget Start
1998-12-21
Budget End
1999-03-08
Support Year
2
Fiscal Year
1998
Total Cost
Indirect Cost
Institution
Name
Sunesis Pharmaceuticals, Inc.
Department
Type
DUNS #
City
South San Francisco
State
CA
Country
United States
Zip Code
94080
Comments
Be the first to comment on Daniel Erlanson's grant
